For xanthelasma, which testing is indicated to evaluate for potential hyperlipidemia?

Prepare for the NBEO Part III Test with detailed quizzes on patient encounters and performance skills. Access flashcards and questions with explanations to enhance your study strategy. Perfect your skills for exam success!

Multiple Choice

For xanthelasma, which testing is indicated to evaluate for potential hyperlipidemia?

Explanation:
Xanthelasma can be a sign of underlying dyslipidemia, so evaluating lipid status is essential. A serum cholesterol and lipid panel provides a full view of lipid levels—total cholesterol, LDL, HDL, and triglycerides—to identify hypercholesterolemia or other lipid abnormalities that may require treatment and cardiovascular risk management. This is typically done as a fasting test to ensure accurate results. The other options don’t assess lipid status: a complete blood count, urinalysis, or skin biopsy may describe general health or confirm the skin lesion but won’t reveal the patient’s lipid profile.

Xanthelasma can be a sign of underlying dyslipidemia, so evaluating lipid status is essential. A serum cholesterol and lipid panel provides a full view of lipid levels—total cholesterol, LDL, HDL, and triglycerides—to identify hypercholesterolemia or other lipid abnormalities that may require treatment and cardiovascular risk management. This is typically done as a fasting test to ensure accurate results. The other options don’t assess lipid status: a complete blood count, urinalysis, or skin biopsy may describe general health or confirm the skin lesion but won’t reveal the patient’s lipid profile.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy